Примери за използване на To each dose на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Shake the bottle vigorously prior to each dose.
Consequently the clinical response to each dose of levodopa is enhanced and prolonged.
In patients with multiple sclerosis,evaluate LVEF by echocardiogram or MUGA prior to each dose;
Patients receiving gemcitabine should be monitored prior to each dose for platelet, leucocyte and granulocyte counts.
Interrupt treatment until recovery to Grade 1 orpre-treatment grade levels prior to each dose.
Additional time may be required prior to each dose escalation based on patient tolerability with Palynziq.
Complete blood counts should be monitored prior to each dose of Polivy.
Haematology laboratory tests should be performed prior to each dose of SYLVANT therapy for the first 12 months and every third dosing cycle thereafter.
Your doctor will monitor your kidney function prior to each dose of VISTIDE.
Women of child-bearing potential should have a negative pregnancy test prior to each dose and must practise effective contraception for at least 4 months after stopping the treatment with Novantrone.
Monitoring of complete blood counts should be performed on all patients prior to each dose of eribulin.
Following initiation of therapy, serum creatinine should be measured prior to each dose of Zometa and treatment should be withheld if renal function has deteriorated.
Due to the risk of hyperbilirubinaemia, it is recommended to monitor bilirubin levels at baseline and prior to each dose.
Analgesics including intravenous opioids should be administered prior to each dose of Unituxin and continued until two hours following completion of Unituxin infusion.
Patients should have their serum creatinine levels assessed prior to each dose of Zometa.
Following initiation of therapy,serum creatinine should be measured prior to each dose of Zoledronic acid Teva and treatment should be withheld if renal function has deteriorated.
Following initiation of therapy,serum creatinine should be measured prior to each dose of Zometa and treatment should be withheld if renal function has deteriorated.
For subsequent cycles, premedication with an H1 antagonist(e.g., diphenhydramine)should be given intravenously 30-60 minutes prior to each dose of olaratumab.
Women of childbearing potential should have a negative pregnancy test prior to each dose, and use effective contraception during therapy and for at least 4 months after cessation of therapy.
Because of the potential for bone marrow suppression,periodic blood counts must be performed frequently during the course of Caelyx therapy, and at a minimum, prior to each dose of Caelyx.
Due to the potential for an acute systemic hypersensitivity reaction, premedication prior to each dose is required during induction and titration(see section 4.2, Method of administration).
Short acting bronchodilators can be taken between 15 minutes and 4 hours and long acting bronchodilators can be taken between 30 minutes and12 hours prior to each dose of Cayston.
Women of childbearing potential must be advised to avoid becoming pregnant;should have a negative pregnancy test prior to each dose and use effective contraception during therapy and for at least 4 months after cessation of therapy.
In order to reduce the potential for nausea and/ or vomiting associated with administration of probenecid,patients should be encouraged to eat food prior to each dose of probenecid.
Complete blood counts should be monitored prior to each dose of BESPONSA and signs and symptoms of infection during treatment and after HSCT(see section 5.1), bleeding/haemorrhage, and other effects of myelosuppression should be monitored during treatment.
Platelet counts should be monitored prior to each dose of VELCADE.
Due to the potential for an acute systemic hypersensitivity reaction, premedication prior to each dose is required during induction and titration(time prior to reaching blood phenylalanine levels less than 600 micromol/l while on a stable dose; see section 4.8).
Complete blood counts should be monitored prior to each dose of MYLOTARG.
In the phase 2 trial, patients in both treatment groups that received 5 ormore cycles of doxorubicin received dexrazoxane prior to each dose of doxorubicin from cycle 5 onwards to minimize the risk of doxorubicin-related cardiotoxicity(see sections 4.8 and 5.1).